The health insurance industry should cover the evaluation and treatment of sexual dysfunction Myron I. Murdock Invited Commentary Pages: 2 - 2
Penile revascularization remains a viable option in the era of oral pharmacotherapy: Pro Yoram VardiIlan Gruenwald Point/Counterpoint Pages: 5 - 7
Penile revascularization remains a viable option in the era of oral pharmacotherapy: Con Eli F. Lizza Point/Counterpoint Pages: 8 - 10
Brachytherapy-associated erectile dysfunction Gregory S. MerrickWayne M. ButlerKent E. Wallner OriginalPaper Pages: 21 - 26
Behavioral and psychologic models in ejaculatory function research David L. RowlandStewart E. Cooper OriginalPaper Pages: 29 - 34
Controversies regarding testosterone supplementation in the prostate cancer patient Jeffrey P. BejmaDena WalshWayne J. G. Hellstrom OriginalPaper Pages: 41 - 44